Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
LE.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5.1.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LE.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDQEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.502EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.285EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.582EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.580EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.306EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.280EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.329EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.396EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.595.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.311EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.369EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.367EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.595EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.240EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.192EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.39.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
ME.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LE.1.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDR.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.49.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HV.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.15.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JD.1.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.441EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.509EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.293EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.225EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.39 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.26 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.103 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.3 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.18.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
MB.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LE.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LF.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
MD.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LP.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.29.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used